Study Finds Rise in Scrotal Cancer Cases
Researchers report a 5.2% annual increase in scrotal squamous cell carcinoma incidence between 2000 and 2023.
Updated on Oct. 27, 2026 in Cancer
Live Poll
Does the rise in specific cancer rates make you more likely to seek early preventive screenings?
A retrospective cohort study covering 2000 to 2023 shows an annual 5.2% increase in the incidence of scrotal squamous cell carcinoma in the United States. The age-adjusted incidence rate for this condition stands at 0.50 per million person-years.
Why it matters
Understanding incidence trends and predictors of survival is essential for improving clinical outcomes for this specific cancer. The research highlights demographic disparities and risk factors that correlate with disease progression.
A study of 1,015 patients found an age-adjusted incidence rate of 0.50 per million person-years. The overall 2-year disease-specific survival rate is 93.0%.
The players
SEER-17
This is a prominent cancer registry program in the United States that collects data on cancer incidence and survival from various geographic areas.
The details
The analysis indicates that Non-Hispanic Black men face the highest incidence rate at 0.84 per million person-years, while Hispanic and Asian/Pacific Islander men show lower rates. Independent predictors of worse disease-specific survival include being over 60, having a tumor larger than 25 mm, and being unmarried.
Timeline
The retrospective study evaluated data collected from 2000 to 2023.
The research study was published online on October 24, 2026.
The Big Picture
The study utilized the SEER-17 cancer registry database protocols to map trends in scrotal cancer incidence. This work extends the utility of the SEER-17 cancer registry database protocols by applying them to rare genital squamous cell carcinomas.
The findings underscore the importance of monitoring for tumor size and age-related health factors during routine checkups. Patients are encouraged to discuss risk profiles with their healthcare providers to improve early detection and long-term survival.
The takeaway
While the incidence of this rare cancer is increasing, the 2-year survival rate remains high at 93.0%. Regular health screenings and awareness of symptoms, particularly for those over 60, remain critical for maintaining positive health outcomes.
Further reading
For more information on current oncology trends, visit the United States Cancer section.
Source note: This article includes information reported by Medscape.
Live Poll
Does the rise in specific cancer rates make you more likely to seek early preventive screenings?
